These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 927284)

  • 1. Experiments with pindolol (Visken) in healthy volunteers.
    Aellig WH
    Med J Aust; 1977 Sep; 2(SP2):8-11. PubMed ID: 927284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.
    Aellig WH
    Br J Clin Pharmacol; 1976 Apr; 3(2):251-7. PubMed ID: 973959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.
    Finch MB; O'Connor PC; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Apr; 15(4):431-4. PubMed ID: 6849778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopharmacological studies with pindolol following intravenous and oral administration].
    Aellig WH
    Adv Clin Pharmacol; 1976; 11():9-13. PubMed ID: 1032575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
    Aellig WH
    Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta blockade and intrinsic sympathomimetic activity on exercise performance.
    Ades PA; Brammell HL; Greenberg JH; Horwitz LD
    Am J Cardiol; 1984 Dec; 54(10):1337-41. PubMed ID: 6507309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
    Aellig WH; Narjes HH; Nüesch E; Oertle RJ; Devos JE; Pacha W
    Eur J Clin Pharmacol; 1981; 20(3):179-83. PubMed ID: 7286035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients.
    Chu D; Cocco G; Schweda E; Haeusler G; Strozzi C
    Eur J Clin Pharmacol; 1980 Aug; 18(2):141-6. PubMed ID: 7428794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers.
    Aellig WH
    Eur J Clin Pharmacol; 1978 Nov; 14(3):167-9. PubMed ID: 729611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the acute haemodynamic effects of propranolol and pindolol at rest and during supine exercise in man.
    Svendsen TL; Carlsen JE; Hartling O; McNair A; Trap-Jensen J
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():465s-468s. PubMed ID: 7449300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.
    Jennings GL; Bobik A; Fagan ET; Korner PI
    Br J Clin Pharmacol; 1979 Mar; 7(3):245-56. PubMed ID: 427002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propranolol and pindolol on cardiac output during extended periods of low-intensity physical activity.
    Broeder CE; Thomas EL; Martin NB; Hofman Z; Jesek JK; Scruggs KD; Wambsgans KC; Wilmore JH
    Am J Cardiol; 1993 Nov; 72(15):1188-95. PubMed ID: 8237812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Robson D
    Br J Pharmacol; 1977 Jul; 60(3):461-9. PubMed ID: 19118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol and pindolol on the up-regulation of lymphocytic beta adrenoceptors during acute submaximal physical exercise. A placebo-controlled double-blind study.
    Mäki T; Näveri H; Leinonen H; Sovijärvi A; Lewko B; Härkönen M; Kontula K
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):544-51. PubMed ID: 1691382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
    Ades PA; Wolfel EE; Hiatt WR; Fee C; Rolfs R; Brammell HL; Horwitz LD
    Eur J Clin Pharmacol; 1989; 36(1):5-10. PubMed ID: 2917588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.